Varenicline decreases alcohol consumption in heavy-drinking smokers

Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats

(2011) Jade J. Bito-Onon et al.   ADDICTION BIOLOGY

A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo

(2011) Dahlia Garza et al.   BIOLOGICAL PSYCHIATRY

A preliminary investigation of varenicline for heavy drinking smokers

(2011) Lisa M. Fucito et al.   PSYCHOPHARMACOLOGY

Thoughts and Acts of Aggression/Violence Toward Others Reported in Association with Varenicline

(2010) Thomas J Moore et al.   ANNALS OF PHARMACOTHERAPY

Activation of  4* nAChRs is Necessary and Sufficient for Varenicline-Induced Reduction of Alcohol Consumption

(2010) L. M. Hendrickson et al.   JOURNAL OF NEUROSCIENCE

Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats

(2010) Susmita Chatterjee et al.   NEUROPSYCHOPHARMACOLOGY

Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers

(2009) Sherry A. McKee et al.   BIOLOGICAL PSYCHIATRY